Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» heart failure
heart failure
Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop
Fierce Pharma
Wed, 07/15/20 - 11:17 am
Novartis
Entresto
heart failure
cardiologists
FDA Grants Breakthrough Designation for Heart Failure Device
Medical Devices and Diagnostics Industry
Thu, 04/23/20 - 09:10 pm
VisCardia
VisOne
heart failure
devices
FDA
ACC: Bayer and Merck’s vericiguat leads off virtual meeting with positive phase 3 heart failure data
Fierce Biotech
Sat, 03/28/20 - 11:25 pm
ACC
Merck
Bayer
heart failure
vericiguat
clinical trials
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
EP Vantage
Sat, 01/18/20 - 07:34 pm
Bayer
Merck
vericiguat
heart failure
AKR-001
Akero Therapeutics
clinical trials
NASH
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
Mon, 01/6/20 - 10:23 am
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Fri, 12/13/19 - 09:05 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Hitting the road: AstraZeneca launches tour to highlight link between diabetes and heart failure
Fierce Pharma
Tue, 12/3/19 - 09:50 am
AstraZeneca
diabetes
type 2 diabetes
heart failure
AstraZeneca, Novoheart to Co-Develop New Heart Model
Xconomy
Wed, 11/27/19 - 10:40 am
AstraZeneca
Novoheart
heart-in-a-jar
heart failure
AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds
Fierce Pharma
Mon, 11/18/19 - 10:29 am
diabetes
AHA
heart failure
Eli Lilly
Boehringer Ingelheim
Jardiance
clinical trials
Janssen taps wearable tech in Invokana heart failure trial
Pharmaforum
Mon, 11/18/19 - 10:05 am
JNJ
Janssen
Invokana
heart failure
wearables
real world evidence
clinial trials
Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure
Pharmaceutical Business Review
Wed, 11/13/19 - 10:02 am
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
Gene therapy to fend off aging? Buzzy Harvard startup Rejuvenate Bio says it works in mice
Fierce Biotech
Tue, 11/5/19 - 10:22 am
gene therapy
age-related disease
type 2 diabetes
obesity
heart failure
kidney failure
Rejuvenate Bio
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
CP Wire
Tue, 10/29/19 - 01:55 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
Highlights: 2019 Cardiometabolic Health Congress, Chicago IL
Tue, 10/29/19 - 01:54 pm
cardiometabolic health
GLP-1 agonist
diabetes
lipids
hypertension
chronic kidney disease
heart failure
obesity
AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
Mon, 10/21/19 - 10:08 am
AstraZeneca
Farxiga
type 1 diabetes
heart failure
EASD: AstraZeneca piles on supporting evidence for Farxiga use in heart failure
Fierce Pharma
Thu, 09/19/19 - 07:59 pm
AstraZeneca
Farxiga
EASD
heart failure
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
Mon, 09/16/19 - 09:28 am
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
AstraZeneca aims to pump up Farxiga marketing after cardio outcomes study
Fierce Pharma
Fri, 09/6/19 - 12:38 pm
AstraZeneca
Farxiga
drug reps
heart failure
Heart failure results could unlock key market for Farxiga – AZ
Pharmaforum
Mon, 09/2/19 - 12:22 pm
AstraZeneca
heart failure
diabetes
Farxiga
ESC: Novartis looks for the bright side in flopped Entresto heart failure study
Fierce Pharma
Mon, 09/2/19 - 12:19 pm
Novartis
heart failure
Entresto
clinical trials
ESC
European Society of Cardiology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »